Alimera Sciences Raises $37.5M Priced near Market via Cowen

Alimera Sciences Inc. (ALIM) announced that it has raised $37,500,000 in a Common Stock transaction. The common stock was sold at $6.00 per share, an approximate 3% discount to the market price ($6.16) of ALIM at deal announcement. Cowen and Company, LLC acted as the exclusive agent on the transaction. Issuer counsel was Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP and Goodwin Procter acted as agent counsel. The private placement is subject to customary closing conditions and is expected to close by 01/31/2014.

Selectica Raises $8.7M in PIPE at 11% Discount from Cannell Capital, Special Situations Funds, Others

Selectica, Inc. (SLTC) announced that it has raised $8,676,450 in a Common Stock transaction. The common stock was sold at $6.00 per share, an approximate 11% discount to the market price ($6.74) of SLTC at deal announcement. A series of 4,338,225 60-Month Warrants with an exercise price of $7.00 per share (3.86% premium) was issued to the investors in this transaction. Lake Street Capital Markets, LLC acted as the exclusive agent on the transaction. The investors include Cannell Capital LLC, Special Situations Funds, Technology Opportunity Partners, LP, and Weber Capital Management, LLC.

ThermoGenesis Raises $6.7M in PIPE at 29% Discount via Maxim Group

ThermoGenesis Corporation (KOOL) announced that it has raised $6,670,000 in a Common Stock transaction. The common stock was sold at $2.00 per share, an approximate 29% discount to the market price ($2.82) of KOOL at deal announcement. A series of 1,667,500 60-Month Warrants with an exercise price of $2.81 per share (0.35% discount) was issued to the investors in this transaction. Maxim Group LLC acted as the exclusive agent on the transaction. The transaction is expected to close by 01/30/2014.

Protalex Raises $2.8M in PIPE at 33% Discount

Protalex, Inc. (PRTX) announced that it has raised $2,828,004 in a Common Stock transaction. The common stock was sold at $6.00 per share, an approximate 33% discount to the market price ($9.00) of PRTX at deal announcement. Warrants were not disclosed. This transaction was completed without an agent. The transaction closed on January 23, 2014.